Tecomet is a scaled global manufacturing partner serving MedTech and other sectors.
Company Background
- Nordic Capital originally invested in Orchid Orthopedic Solutions, a leading orthopaedic manufacturing partner providing differentiated capabilities across implants, instruments and innovative technologies within joint reconstruction, hips, knees, spine, trauma, extremities and dental.
- In May 2026, Orchid completed its merger with Tecomet, with the combined company operating under the Tecomet name. The combination brings together Orchid’s differentiated orthopaedic manufacturing and next-generation additive platform with Tecomet’s broader manufacturing capabilities and footprint, creating a scaled, more resilient platform with a more complete end-to-end offering for MedTech OEMs.
Vision & Outlook
- Leverage the combined company’s complementary capabilities and integrated manufacturing platform to strengthen customer partnerships and support long-term growth.
SECTOR
Healthcare
REVENUES 2025
EUR 685 million
EMPLOYEES
3,500
OWNERSHIP
Fund IX
INVESTMENT DATE
2019
HEAD OFFICE
Woburn, Massachusetts, USA
